Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlou Tablets for Coronary Heart Disease with Turbid Phlegm and Blood Stasis
NCT02526381Unknown
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, open-label trial of danlou in coronary heart disease (CHD) (3 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Traditional Chinese Medicine symptom scores of Turbid Phlegm and Blood Stasis for Coronary Heart Disease at 12 weeks, Seattle Angina Questionnaire at 12 weeks and 2 more. Status: unknown.
02
Drugs
danlou
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT02526381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526381.